English

Pfizer Canada Invests $750,000 in Q-CROC

PHILADELPHIA (Pennsylvania), June 3, 2019 – Pfizer Canada is proud to announce a $750,000 contribution to Q-CROC to address numerous...

Did you know that the month of May is associated with clinical research? From May 13th to 24th, more than twenty Q-CROC hospital members...

Montreal, November 6, 2018 - The Quebec – Clinical Research Organization in Cancer (Q-CROC) and the Oncopole are proud to announce the...

Would you like to know more about clinical trials? Several awareness-raising activities will take place in Quebec during the month of...

Cancer clinical trials are a critical part of bringing new therapies to life. These studies are made possible by patients who agree to...

Researchers in Canada are seeking feedback on your experience with declining or participating in a clinical trial via an on-line,...

On March 22nd, all Q-CROC liaison coordinators attended the 52nd RALi (Rencontre des agents de liaison) teleconference meeting, along...

CCTCC Fair Market Value (FMV) Working Group (WG) On March 6th, representatives from several healthcare institutions and pharmaceutical...

The board of directors of the CHUM Research Centre (CRCHUM) has announced the appointment of Dr. Normand Blais as Assistant Scientific...

Q-CROC welcomes the announcement of the creation of the Oncopole, born from a public-private partnership between the Fonds de recherche...